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Abstract
OBJECTIVE—Low-density lipoprotein-related receptor protein 1 (LRP1) is a multi-functional
endocytic receptor and signaling molecule that is expressed in adipose and the hypothalamus.
Evidence for a role of LRP1 in adiposity is accumulating from animal and in vitro models, but
data from human studies are limited. The study objectives were to evaluate (i) relationships
between LRP1 genotype and anthropometric traits, and (ii) whether these relationships were
modified by dietary fatty acids.
DESIGN AND METHODS—We conducted race/ethnic-specific meta-analyses using data from
14 studies of US and European whites and 4 of African Americans to evaluate associations of
dietary fatty acids and LRP1 genotypes with body mass index (BMI), waist circumference and hip
circumference, as well as interactions between dietary fatty acids and LRP1 genotypes. Seven
single-nucleotide polymorphisms (SNPs) of LRP1 were evaluated in whites (N up to 42 000) and
twelve SNPs in African Americans (N up to 5800).
RESULTS—After adjustment for age, sex and population substructure if relevant, for each one
unit greater intake of percentage of energy from saturated fat (SFA), BMI was 0.104 kg m−2
greater, waist was 0.305 cm larger and hip was 0.168 cm larger (all P<0.0001). Other fatty acids
were not associated with outcomes. The association of SFA with outcomes varied by genotype at
rs2306692 (genotyped in four studies of whites), where the magnitude of the association of SFA
intake with each outcome was greater per additional copy of the T allele: 0.107 kg m−2 greater for
BMI (interaction P=0.0001), 0.267 cm for waist (interaction P=0.001) and 0.21 cm for hip
(interaction P=0.001). No other significant interactions were observed.
CONCLUSION—Dietary SFA and LRP1 genotype may interactively influence anthropometric
traits. Further exploration of this, and other diet x genotype interactions, may improve
understanding of interindividual variability in the relationships of dietary factors with
anthropometric traits.
Keywords
low-density lipoprotein receptor-related protein 1; SNPs; saturated fatty acids; gene–diet
interactions
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Obesity prevalence continues to increase globally,1,2 but a proportion of individuals
experience less weight gain in spite of apparently similar environments. Characterizing the
extent to which genetic and environmental factors, for example, diet, interact to influence
weight gain may help to clarify the relevant mechanisms. In spite of the potential value of
such research, well-designed investigations of gene–diet interactions are relatively few.
Given the likely small magnitude of such interactions and the relatively high degree of
measurement error inherent in the characterization of dietary intake, sample sizes needed to
detect statistically significant interactions are much larger than most single population
studies provide.3,4 Combining studies through meta-analysis increases sample size to
address this challenge, but meta-analysis using published data is handicapped by
heterogeneous definitions of exposures, inconsistent statistical methods and publication
bias.5 Alternatively, a collaborative, multi-study approach where contributing studies
centrally design analytic plans and consequently supply comparable genetic and phenotypic
data may provide sufficient power and data consistency to detect gene–environment
interactions,6–9 and avoid the potential bias of relying on published data alone. In summary,
key features of the planned multi-study approach that may improve reliability compared
with traditional meta-analytic approaches include: (1) meta-analysis of data from studies of
similar design and purpose, (2) application of similar statistical and genetic models across
studies and (3) standardization of exposures (for example, dietary data) to the fullest extent
possible.
Planned multi-study approaches may be particularly useful when applied to complex,
longstanding questions, such as the relationship between macronutrient intake (for example,
fats, carbohydrates, proteins) and body weight. Despite decades of study, the role of dietary
composition in body weight continues to be debated and has been extensively
reviewed.10–12 In one meta-analysis, low-fat diets were associated with greater weight
loss,13 and fat intake has been associated with greater energy consumption across a range of
typical fat intakes.14 In other studies, including clinical trials in which energy intake was
similar across groups, proportions of dietary macronutrients were unrelated to weight
loss.15,16 Specific foods, rather than macronutrients, were shown in one study to be linked to
body weight changes.17 However, genetic variation may also account, in part, for the
conflicting data, as indicated by recent interaction studies in which dietary fat intake
modulated the relationship between genetic loci and body weight.18–20
An emerging new obesity candidate gene that may respond to dietary fat is that of the
endocytic receptor, low-density lipoprotein receptor-related protein 1, encoded by LRP1.
Most of the evidence for a role of LRP1 in obesity comes from in vitro and animal knockout
models21–24 but two human studies were recently published. One study reported the
association of LRP1 rs715948 genotype with body mass index (BMI) in US whites25 and a
second documented an interaction between LRP1 rs1799986 and diet, in which saturated fat
intake modulated anthropometric traits in US Puerto Ricans.26 Notably, each of these
previous studies was limited to a single population. Although data supporting a role of LRP1
variants in obesity are accumulating, investigations that include interaction analyses in
additional populations are warranted.
Therefore, the objective of the current study was to evaluate relationships of selected LRP1
genotypes and dietary fatty acids, and also their interactions, for the outcome of
anthropometric traits. We performed separate analyses in 14 independent US or European
studies (N up to 42 000 whites) and four US studies (N up to 5800 African Americans).
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We evaluated (i) main associations of each genetic variant and dietary fatty acids for
anthropometric traits and (ii) interactions between dietary fatty acids and genetic variants for
anthropometric traits were performed in 14 studies (Table 1, Supplementary Table 1). In
four of the US cohorts, data for African American individuals were also available. Only
participants with dietary or genetic data that met study-specific quality control standards
were included in the analyses (Supplementary Tables 2 and 3). Informed consent for study
participation and consent to use genetic data were provided by all participants whose data
were analyzed, and study protocols were reviewed by institutional review boards for each
study.
Dietary assessment and estimation of fatty acids intake as a percentage of total energy
Previous studies investigating gene–fatty acids interactions have most frequently analyzed
saturated fatty acids (SFAs) and polyunsaturated fatty acids (PUFAs).18–20,27,28 In addition,
animal and cell models have provided evidence that LRP1 may be responsive to these fatty
acids.29–31 Estimations of SFA and PUFA intakes were derived from food frequency
questionnaires in all studies (Supplementary Table 2) using the reported frequency and
portion sizes and corresponding macronutrient compositions of relevant foods, as provided
in region-specific reference databases. Fatty acid intake was characterized as percentage of
total energy intake, calculated as 100*((grams of fatty acid × 9)/total energy). Fatty acid
intakes were evaluated continuously and dichotomously (divided into high and low based on
study-specific median intakes) to evaluate dose–response and threshold effects, respectively.
Anthropometric traits
Analyses were performed for BMI, waist circumference and hip circumference. Waist
circumference has been associated with adverse metabolic consequences in ethnically
diverse individuals32 and hip circumference has been shown to be protective.33 Study-
specific methods for measuring height and weight (to calculate BMI in kg m−2), and waist
and hip circumference are described for each study (Supplementary Table 4).
SNP selection and genotyping
LRP1 genotype data were downloaded separately for CEU (individuals of Western and
Northern European origin) and YRI (Yoruba in Nigeria) from HapMap phase 2. For each
racial group, genotype data were imported into Haploview,34 minimum allele frequency
threshold was set to 0.05 and pair-wise tagging was applied with an r2 threshold of 0.2 to
obtain independent single-nucleotide polymorphisms (SNPs). Seven tag SNPs were selected
for CEU and twelve tag SNPs for YRI for evaluation. Methods for genotyping including
genome-wide chip technology, quality control and imputation methods are described for
each cohort (Supplementary Table 3).
Statistical analyses by each study
Each study performed linear regression analysis to generate regression coefficients (β) and
standard errors for (1) associations of LRP1 genotype with anthropometric traits, (2)
associations between continuously evaluated fatty acid intake (SFA and PUFA) and
anthropometric traits (3) interactions between LRP1 genotype and dietary fatty acids with
respect to anthropometric traits.
Genotype associations models used an additive genetic model with adjustment for age
(continuous), sex, field center and cohort-specific principal components (as needed to
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account for population substructure and/or family structure). Associations between fatty
acids and anthropometric traits (without inclusion of genotypes or interaction terms in the
model) were evaluated using three hierarchical models: (model 1) age (years, continuous),
gender, population substructure variables; (model 2) model 1+total daily energy intake
(kcal/day, continuous; and (model 3) model 2+smoking status (categorical), physical activity
(continuous, based on study-specific metric), alcohol intake (continuous)), education (based
on study-specific metric). Study-specific covariate definitions are presented in
Supplementary Table 5.
Fatty acids–SNP interactions were evaluated using cross-product terms using the likelihood
ratio test with an additive genetic model. Thus, the interaction regression coefficient
represents the difference in the magnitude of the fatty acid association (per each +1 percent
of total energy) with anthropometric outcomes (BMI, waist or hip) per copy of the effect
allele.
Meta-analysis
Meta-analysis was performed using an inverse variance-weighted, fixed effects approach.
For SNP associations and for SNP × fatty acids interaction meta-analysis, METAL software
was used (http://umich.edu/csg/abecasis/Metal/). For fatty acids associations, R software
was used.35 Within each ethnic group, all available studies were meta-analyzed in order to
maximize statistical power. Bonferroni correction based on the number of SNPs and the two
types of nutrients tested (SFA and PUFA) was applied to establish a significance level with
correction for multiple testing. Seven SNPs were evaluated in whites (α=0.05/7 * 2=0.004)
and twelve SNPs in African Americans (α=0.05/12 * 2=0.002).
RESULTS
Participant characteristics and study descriptions are provided for each group (Table 1,
Supplementary Table 1). SFA intake ranged from 9.4% of total energy (in Health Aging and
Body Composition study (white participants)) to 14.4% (Rotterdam Study). PUFA intake
ranged from 3.4% (InCHIANTI) to 8.7% (Health ABC, white participants). Allele
frequencies and chromosomal positions for each SNP are shown for each study for whites
and African Americans (Supplementary Table 6). Results described below are derived from
meta-analysis of all cohorts in which genotype data were available with the number of
studies for each SNP/trait combination provided in the table.
Associations of SFAs and PUFA intake with anthropometrics
Percentage of energy from SFA was associated with higher BMI and waist and hip
circumference in whites adjusted for age, gender and population substructure variables
(Table 2). Similar results were obtained with additional adjustment for lifestyle factors,
including physical activity, smoking, alcohol, education level and total energy intake (Table
2). For each one percentage greater intake of energy from SFA, BMI was 0.104 kg m−2
greater, waist circumference was 0.305 cm larger and hip circumference was 0.168 cm
larger (all P<0.0001). In African Americans, associations of SFA intake with BMI and hip
circumference were similar to those observed in whites (Table 2). No associations between
fatty acids and waist circumference were observed in African Americans.
Associations of LRP1 SNPs with anthropometrics
With adjustment for age, sex, and study-specific population substructure measures, none of
the LRP1 SNPs were associated with BMI, waist circumference, or hip circumference in
whites. In African Americans, BMI was 0.726 kg m−2 lower (P=0.017) and hip was 3.404
cm lower (P=0.015) per copy of the A allele for LRP1 rs1800141 (Table 3).
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Interactions between LRP1 SNPs and SFA intake for anthropometrics
Of the seven variants tested for interaction in whites, only LRP1 rs2306692 showed
statistically significant evidence of interaction with SFA intake (Table 4; genotyped in only
four white cohorts, N~13,000). For each one percentage greater intake of energy from SFA,
BMI was 0.107 kg m−2 greater (interaction P=0.0001), waist circumference was 0.267 cm
larger (interaction p=0.001) and hip circumference was 0.21 cm larger (interaction P=0.001)
per one additional copy of the effect allele (T). In other words, the magnitude of the
association between SFA intake and these anthropometric traits was greater in the presence
of the T allele compared with the absence of the T allele. Results were similar when SFA
was modeled dichotomously using sample-specific median cut points (Supplementary Table
7). We did not observe corresponding statistically significant interactions between SFA and
rs2306692 in African Americans (Table 3; genotyped in four cohorts, N~13 000). The
remaining SNP–SFA interactions tested in African Americans were also not statistically
significant (Table 3).
Interactions between LRP1 SNPs and PUFA intake for anthropometrics
Interactions between LRP1 SNPs and PUFA were evaluated continuously (Table 5) and
dichotomously (Supplementary Table 8); none were statistically significant in either race/
ethnic group.
DISCUSSION
We observed an interaction between an LRP1 variant and saturated fat intake for
anthropometric traits in whites using a meta-analytic approach that incorporated data from
multiple populations. Specifically, the magnitude of the association between SFA and
anthropometric traits was greater per each additional copy of the T allele for LRP1
rs2306692. Although the differences in the slope of these associations were modest (BMI
was 0.107 kg m−2 greater, waist circumference was 0.267 cm greater, and hip circumference
was 0.21 cm greater), and the SNP available in a relatively small sample, these data provide
preliminary evidence that dietary factors and genetic factors at this locus may interactively
influence body size. Although in this instance we have described the `interaction' in terms of
genetic modulation of a dietary association, these findings could alternatively be interpreted
as dietary modulation of an association between genetic variants and body size.
The majority of existing literature on the role of LRP1 in adiposity is based on animal and in
vitro models. A large-scale (n~123 000 with follow-up in ~126 000) meta-analysis of
genome-wide association studies did not identify statistically significant associations
between the LRP1 SNPs evaluated in our report and BMI, but interactions with dietary
factors were not analyzed in that meta-analysis.36 A single observational study in adults did
report an association between LRP1 rs715948 and BMI in a white population,25 but this
association was not replicated in our larger meta-analysis. Similarly, we did not replicate an
interaction between SFA and a second LRP1 variant (rs1799986) that was observed in a
separate study of Boston Puerto Ricans.26 Neither of these two previous single population
studies analyzed rs2306692, the variant that showed statistically significant interaction with
SFA intake for anthropometric traits in our meta-analysis of data from four studies.
Inconsistencies in genetic association studies are common, and may be attributed to
undetected environmental interactions, differences in confounding variables or false-positive
results obtained in single populations. Differences in linkage disequilibrium across ethnic
groups may also contribute to variable results. In the current study, SNPs were intentionally
selected to minimize linkage disequilibrium (r2<0.2) within each of the two ethnic groups,
but these patterns may differ in groups with other ancestries.
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Mechanisms for the observed interaction between rs2306692 and SFA can be hypothesized,
but not directly evaluated in the current study. LRP1 is expressed in many tissues, including
adipose and the hypothalamus,24 and both sites have been implicated in obesity. Previous
studies with animal models demonstrated a role for LRP1 in adipogenesis, obesity and fat
storage, with adiposespecific knockout conferring resistance to obesity.21–23 In contrast,
hypothalamic-specific knockout of LRP1 resulted in greater food consumption compared
with controls, and an obese phenotype accompanied by insulin resistance.24 Of potential
relevance to eating behavior is LRP1's regulation of leptin, in that LRP1 binding to leptin is
required for activation of Stat3 (signal transduction-activated transcript-3), a transcription
factor whose knockout also promotes appetite and weight gain.24,37 Interestingly, SFA have
been reported to modulate the relationship between genotype and adiposity for STAT3, as
we report here for LRP1, in that high SFA intake was linked to obesity in carriers of STAT3
variants.18 Moreover, additional genes encoding the hypothalamically expressed FTO and
the postulated satiety signal apolipoprotein A-II (APOA2)19,38 also appear to be modulated
by SFA. At both FTO and APOA2 loci, the presence of variant alleles in individuals
consuming high SFA is associated with greater body weight compared with individuals
without the variants. We therefore postulate a hypothetical model in which high SFA intake
promotes obesity via disruption of hypothalamic signaling pathways that regulate satiety and
intake, for which genetic variants of LRP1, STAT3, FTO, APOA2 and others as yet
unidentified interact biologically with SFA to shape the pattern of disruption.
The primary goal of the current study was investigation of gene–nutrient interactions, but we
also examined fatty acids and anthropometric traits without evaluation of genotype. Intakes
of SFA, but not PUFA, were associated with greater BMI, waist circumference and hip
circumference. Although we adjusted by major lifestyle factors, including physical activity,
smoking, alcohol and education, we did not evaluate the role of other potential confounders
related to food choices (for example, dietary fiber, fruits and vegetables, socioeconomic
factors) and food sources of SFA. In animal models, SFA intake is associated with
hypothalamic activation of Toll-like receptor signaling and impaired anorexigenic signaling
that are hypothesized to contribute to obesity via increased energy intake.39 However, in
people, specific foods (including red meat and processed meats, sugar-sweetened beverages,
potato chips), rather than specific nutrients, were shown to be associated with weight gain
over time.17 Greater SFA intake may represent a marker for correlated dietary and
behavioral factors that promote greater body size.
Our study is strengthened by its centrally designed analysis plan of primary data, large
sample size and examination of multiple SNPs across the LRP1 locus; however, our findings
do not provide evidence of SNP functionality. In addition, genotypes for LRP1 rs2306692
were measured in only 4 of the 14 white populations, and its availability in a comparatively
small number of subjects (n ~ 13 000) is an important limitation. The absence of interaction
in African Americans provides evidence against LRP1 rs2306692 being causal, as a
functional SNP would be likely to demonstrate similar relationships cross-ethnically.
Instead, rs2306692 could be a marker for a functional SNP, and the marker could differ
across ethnic groups. Future studies testing the reliability of our findings could also utilize
sequencing data to identify less common, and potentially functional, LRP1 variants to which
rs2306692 is linked.
In summary, from a meta-analysis of data from four US and European cohort studies, we
observed an interaction between LRP1 genotype and SFA intake for anthropometric traits.
LRP1 rs2306692 may represent a marker for greater sensitivity to SFA or to correlated
lifestyle behaviors, leading to greater probability of higher body weight in the context of a
diet high in saturated fats, such as the Western diet. Confirmation of these findings in the
context of an interventional study that targets SFA intake and considers LRP1 genotype is
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needed to confirm that these relationships are valid in the context of dietary change. In spite
of the importance of extending interaction analyses beyond a single population, replications
and meta-analyses of interactions are relatively rare. This study represents one of a small,
but growing, number of studies that apply centrally planned, collaborative methods to
improve the reliability of genetic findings.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Table 1
Participant characteristics by study






























2980 52.9 ± 13.8 52.9 27.7 ± 5.5 97.7 ± 15.2 105.8 ± 11.2 30.5 ± 7.5 11.2 ± 3.2 4.5 ± 1.4































2289 62.6 ± 10.3 51.6 27.8 ± 5.1 98.0 ± 14.3 106.2 ± 10.5 33.4 ± 7.2 11.0 ± 3.3 7.0 ± 2.0
 Nurses Health








1762 37.8 ± 5.0 56 26.0 ± 4.8 88.5 ± 13.5 99.8 ± 8.9 32.8 ± 4.8 11.8 ± 2.4 5.3 ± 1.1
African Americans
 Atherosclerosis
Risk in 3078 53.4 ± 5.8 62 29.6 ± 6 102.8 ± 15.6 110.4 ± 13.7 32.1 ± 6.4 11.4 ± 2.7 4.8 ± 1.3
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1313 62.2 ± 10 53.5 30 ± 5.7 101 ± 14.3 109.5 ± 11.9 34.5 ± 7.1 10.6 ± 2.9 7.6 ± 2.2
Abbreviations: BMI, bodv mass index; NA, not available.
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Table 2





















  Saturated fatty acids
  Model 1 42 884 0.104 (0.089, 0.118) < 0.0001 40 368 0.305 (0.263, 0.346) < 0.0001 34 709 0.168 (0.134, 0.202) < 0.0001
  Model 2 42 884 0.107 (0.093, 0.122) < 0.0001 40 367 0.304 (0.262, 0.346) < 0.0001 34 709 0.169 (0.134, 0.204) < 0.0001
  Model 3 39 173 0.088 (0.0727, 0.104) < 0.0001 36 754 0.252 (0.208, 0.297) < 0.0001 31 363 0.141 (0.104, 0.178) < 0.0001
  Polyunsaturated fatty acids
  Model 1 42 884 0.02 (−0.002, 0.041) 0.072 40 368 0.054 (−0.008, 0.115) 0.086 34 709 0.046 (−0.004, 0.096) 0.070
  Model 2 42 884 0.023 (0.001, 0.044) 0.038 40 367 0.054 (−0.007, 0.116) 0.085 34 709 0.046 (−0.004, 0.096) 0.071
  Model 3 39 173 0.006 (−0.015, 0.027) 0.598 36 754 0.051 (−0.009, 0.111) 0.094 31 363 0.02 (−0.029, 0.068) 0.426
African Americans
  Saturated fatty acids
  Model 1 5834 0.05 (−0.002, 0.102) 0.060 4791 −0.015 (−0.053, 0.024) 0.448 3673 0.148 (0.029, 0.266) 0.015
  Model 2 5834 0.059 (0.006, 0.112) 0.03 4791 −0.008 (−0.047, 0.031) 0.696 3673 0.162 (0.041, 0.284) 0.009
  Model 3 5767 0.057 (0.003, 0.111) 0.038 4736 0.126 (0.014, 0.239) 0.028 3628 0.236 (0.1, 0.372) 0.0007
  Polyunsaturated fatty acids
  Model 1 5831 0.044 (−0.03, 0.118) 0.239 4788 −0.025 (−0.065, 0.014) 0.211 3670 0.075 (−0.073, 0.223) 0.322
  Model 2 5831 0.046 (−0.028, 0.12) 0.222 4788 −0.021 (−0.059, 0.017) 0.285 3670 0.082 (−0.063, 0.227) 0.265
  Model 3 5764 0.036 (−0.038, 0.11) 0.337 4733 0.012 (−0.093, 0.118) 0.818 3625 0.129 (−0.035, 0.292) 0.123
Abbreviations: BMI, body mass index; CI, confidence interval. Model 1: age, gender, population-specific substructure. Model 2: model 1 + total
daily energy intake. Model 3: model 2 + smoking status, physical activity, alcohol intake, education.
a
β Represents estimated difference in anthropometric trait per + 1-unit intake of fatty acid expressed as a percentage of total daily energy.
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